Nerissa Kreher, Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA), sold 5,200 shares at $13.45 ($70K) on 2022-12-30, disclosed to the SEC on 2023-01-03.
Open-market sale of $70k TRDA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRDA | SELL | 2023-08-04 | $771K | — | Filing → |
| TRDA | SELL | 2023-03-03 | $17K | — | Filing → |
| TRDA | SELL | 2022-10-27 | $537K | — | Filing → |